创新驱动，引领生物医药
Junshipharma (junshipharma.com) scores 68 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, in the 17th percentile of 13258 Healthcare brands.
Junshipharma (君实生物) is a Chinese biopharmaceutical company founded in December 2012. It is driven by innovation, focusing on the discovery, development, and commercialization of novel therapies. The company concentrates on oncology, autoimmune diseases, chronic metabolic diseases, and infectious diseases, aiming to build an internationally competitive pipeline of biopharmaceutical products based on its own R&D capabilities, serving patients, medical institutions, and industry partners worldwide.
| Brand Name | Junshipharma |
|---|---|
| Domain | junshipharma.com |
| Industry | Healthcare |
| Founded | 2012年12月 |
| Main Competitors | BeiGene (85/100), Innovent Biologics (67/100), Jiangsu Hengrui Medicine (Hengrui Pharma) (62/100), Akeso (71/100), Shanghai Fosun Pharmaceutical (71/100), Merck & Co. (Keytruda) (81/100), Bristol Myers Squibb (Opdivo) (89/100) |
Moz Domain Authority 34/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #4,606,220 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "君实生物成立于2012年12月，是一家以创新为驱动，致力于创新疗法的发现、开发和商业化的生物制药公司。" (Meta description too short (1 words). OG description present but brief) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Content is ZH-only, limiting citation in English-language AI answers.
Detected tech stack: Apache, WordPress, Ghost.
Social footprint: verified profiles on Facebook, Instagram, GitHub; no detected presence on X (Twitter), LinkedIn, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Junshipharma?", Claude could not identify the brand as of October 2026. I don't genuinely recognize a company called Junshipharma at this specific website, though it may be a smaller or regional firm, possibly confusable with Junshi Biosciences, a Chinese biopharmaceutical company, but I can't confirm details about this exact entity.
When asked "Best brands similar to Junshipharma?", Claude would not surface Junshipharma as of October 2026. Since I can't verify what Junshipharma actually does or confirm its reputation, I wouldn't bring it up without risking inaccurate information.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Junshipharma's main competitors in Healthcare: BeiGene (85/100), Innovent Biologics (67/100), Jiangsu Hengrui Medicine (Hengrui Pharma) (62/100), Akeso (71/100), Shanghai Fosun Pharmaceutical (71/100).
Sources: Brand Analyzer scan
Junshipharma has low AI-search visibility, scoring 23/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 39, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Junshipharma official site
Junshipharma scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Junshipharma official site
Junshipharma can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Junshipharma official site
Junshipharma, known formally as Junshi Biosciences (君实生物), is a Chinese biopharmaceutical company founded in December 2012. It is an innovation-driven firm dedicated to the discovery, development, and commercialization of novel therapeutics, with operations spanning research, clinical development, and manufacturing of biologic drugs.
Sources: Junshipharma official site
Junshipharma discovers, develops, and commercializes innovative biopharmaceutical products. Its research and development activities focus on oncology, autoimmune diseases, chronic metabolic diseases, and infectious diseases. The company leverages its own R&D capabilities to build a pipeline intended to be internationally competitive, serving patients, medical institutions, and industry partners.
Sources: Junshipharma official site
Junshipharma scores 23/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Junshipharma has a weak AI-visibility profile at 23/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (0/100). It benefits from a global traffic rank of #4,606,220 (Tranco), open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 34/100. In a live check (October 2026), Claude could not identify Junshipharma from memory, confirming the gaps above.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Junshipharma: JumpTech (68/100), Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER) (68/100), Juvena Therapeutics (68/100), Keriton (68/100).
A step up - brands to learn from: ZT Corporate (71/100), Zorgnet-Icuro (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.